Practice area 02
Compliance Programs and Risk Assessments
Compliance programs built to work in real operating environments, informed by experience designing programs, managing risk inside companies and investigating what happens when controls fail.
When clients call
Where programs need attention
- Expanding commercial activity, or preparing for commercialization
- Updating procedures after new government guidance, such as OIG guidance on speaker programs
- Testing whether high-risk functions operate as designed
- Remediating after an investigation or government inquiry
- Building controls for distributors and other third parties
- Training managers and sales teams on how the rules apply to their work
Services
Risk assessments, program design, privileged reviews and remediation
Risk assessments
Interviews, document review and data analysis to identify and rank the risks that matter most to your business.
Program design
Policies, procedures and controls that commercial, medical and operations teams can actually follow, sized to your company’s stage.
Privileged reviews
Reviews of high-risk functions conducted with your internal audit team and, where appropriate, structured to support privilege.
Remediation
Practical corrective action after an investigation, audit finding or government inquiry, from root cause to updated controls.
Also available: on-site and remote training for management and sales teams.
Focus areas
Where risk concentrates
HCP engagement
Speaker programs, consulting arrangements, meal spend and other payments to health care professionals
Patient support
Patient assistance, nurse educators, patient support managers and reimbursement coordinators
Grants and foundations
Research grants and grants to co-pay assistance foundations
Pricing and promotion
Drug pricing and off-label promotion
Third parties
Distributor controls, anti-bribery, anti-money laundering and third-party engagement
What to expect
Programs your teams can run
Recommendations are prioritized by risk, sized to your company’s stage and resources, and written for the people who have to follow them. Having run these functions from inside pharmaceutical companies, and having investigated what happens when controls break down, I focus on what will work in practice.
Related
Building or rebuilding a compliance program?
Start with a brief, general description of where you are and what you need.